https://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-astex-pharmaceuticals-inc-222542851.html
/PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Astex Pharmaceuticals Inc. ("Astex" or...
astex pharmaceuticalsharwoodfefferllpannounces
https://www.pharmaceutical-technology.com/data-insights/guadecitabine-sodium-astex-pharmaceuticals-peripheral-t-cell-lymphomas-ptcl-likelihood-of-approval/
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Peripheral T-Cell Lymphomas (PTCL).
astex pharmaceuticalssodiumperipheralcelllymphomas
https://www.pharmaceutical-technology.com/data-insights/guadecitabine-sodium-astex-pharmaceuticals-small-cell-lung-cancer-likelihood-of-approval/
Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for Small-Cell Lung Cancer.
astex pharmaceuticalssmall celllung cancersodium